The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
- PMID: 3906410
- DOI: 10.1038/318533a0
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Abstract
Transgenic mice bearing the cellular myc oncogene coupled to the immunoglobulin mu or kappa enhancer frequently develop a fatal lymphoma within a few months of birth. Since the tumours represent represent both immature and mature B lymphocytes, constitutive c-myc expression appears to be highly leukaemogenic at several stages of B-cell maturation. These myc mice should aid study of lymphoma development, B-cell ontogeny and immunoglobulin regulation.
Similar articles
-
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.Cell. 1986 Oct 10;47(1):11-8. doi: 10.1016/0092-8674(86)90361-2. Cell. 1986. PMID: 3093082
-
The transgenic window on lymphoid malignancy.Princess Takamatsu Symp. 1989;20:297-309. Princess Takamatsu Symp. 1989. PMID: 2518688
-
Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.Mol Cell Biol. 1987 Apr;7(4):1436-44. doi: 10.1128/mcb.7.4.1436-1444.1987. Mol Cell Biol. 1987. PMID: 3037318 Free PMC article.
-
Chromosome translocations in B and T cell neoplasias.Semin Hematol. 1986 Oct;23(4):237-44. Semin Hematol. 1986. PMID: 3535082 Review. No abstract available.
-
Transgenic mice as a means to study synergism between oncogenes.Int J Cancer Suppl. 1989;4:22-5. doi: 10.1002/ijc.2910440706. Int J Cancer Suppl. 1989. PMID: 2681009 Review.
Cited by
-
Critical DNA damaging pathways in tumorigenesis.Semin Cancer Biol. 2022 Oct;85:164-184. doi: 10.1016/j.semcancer.2021.04.012. Epub 2021 Apr 24. Semin Cancer Biol. 2022. PMID: 33905873 Free PMC article. Review.
-
BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription.Cell Death Dis. 2024 Aug 26;15(8):621. doi: 10.1038/s41419-024-06996-w. Cell Death Dis. 2024. PMID: 39187513 Free PMC article.
-
BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression.Blood Adv. 2020 Jul 28;4(14):3316-3328. doi: 10.1182/bloodadvances.2020002231. Blood Adv. 2020. PMID: 32717030 Free PMC article.
-
A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.Genes Dev. 2016 Aug 15;30(16):1811-21. doi: 10.1101/gad.284851.116. Epub 2016 Aug 26. Genes Dev. 2016. PMID: 27566778 Free PMC article.
-
Ribosomal protein S14 negatively regulates c-Myc activity.J Biol Chem. 2013 Jul 26;288(30):21793-801. doi: 10.1074/jbc.M112.445122. Epub 2013 Jun 17. J Biol Chem. 2013. PMID: 23775087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials